Biosafety Guidelines for Viral Vector-Based Gene Therapies: A Resource for Healthcare and Pharmacy Professionals
By adopting the biosafety strategies outlined in this article, healthcare staff and pharmacists can safely manage viral vectors while developing standard operating procedures tailored to their specific clinical environments. Implementing these measures will support the continued advancement of gene therapy while ensuring the safety of healthcare providers, patients, and the environment.
Authors
- Samantha Parsons (ORCID: https://orcid.org/0000-0001-5949-3899)
- Sumit Ghosh (ORCID: https://orcid.org/0000-0002-6890-954X)
- Jill E Blind (ORCID: https://orcid.org/0000-0003-3450-2175)
- Katie Campbell
- Allison M. Fowler
- Kembral L. Nelson
Institutions
- Nationwide Children's Hospital (US)
Publication Details
- Journal
- Applied Biosafety
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1089/apb.2024.0057
- Citations
- 2
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 3.63